Autres langues Photocure ASA

Actions

PHO

NO0010000045

Produits pharmaceutiques

Marché Fermé - Oslo Bors Autres places de cotation 16:45:00 03/08/2026			Varia. 5j.	Varia. 1 janv.
51,70 ^NOK	-2,45%		-9,14%	-27,59%

29/07	Transcript : Photocure ASA, Q2 2026 Earnings Call, Jul 29, 2026
29/07	Photocure ASA publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

29/07	Photocure ASA - Share option grant
29/07	Photocure ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Photocure ASA: Results for the second quarter of 2026
23/07	Photocure : initiates arbitration in partial milestone payment case with Asieris Pharmaceuticals
22/07	Photocure ASA: Invitation to presentation of second quarter 2026 financial results
14/07	Photocure ASA - Share option grant
30/06	Photocure ASA Announces CFO Transition
30/06	Photocure CFO to Retire
30/06	Photocure ASA - CFO transition
26/06	Photocure ASA: Annual general meeting held
09/06	Photocure, Artera Enter Research Partnership for Bladder Cancer Diagnostics
08/06	Photocure ASA and Artera Partner on Digital Pathology AI Test Evaluation for Bladder Cancer
08/06	Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer
05/06	Photocure ASA - Notice of the Annual General Meeting 26 June 2026
04/06	Photocure Buys US-based Vesica Health for $31 Million
04/06	Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics
04/06	Photocure ASA acquired remaining stake in Vesica Health for $27.5 million.
18/05	AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study
18/05	Photocure ASA Presents New Studies Demonstrating Blue Light Cystoscopy Benefits In High-Risk NMIBC Management And Cost Comparison
07/05	Photocure Q1 reported EBITDA at NOK 128.3 million
07/05	Photocure ASA: Results for the first quarter of 2026
07/05	Photocure ASA Reports Earnings Results for the First Quarter Ended March 31, 2026
04/05	New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer
30/04	Photocure ASA: Invitation to presentation of first quarter 2026 financial results
27/04	Photocure ASA: Annual Report 2025